Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs

Clinical Infectious Diseases

Volumn 53, Issue SUPPL. 1, 2011, Pages

  File, Thomas M ^a,b   Solomkin, Joseph S ^c   Cosgrove, Sara E ^d  

^a Northeastern Ohio Medical University   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CLARITHROMYCIN; DORIPENEM; DOXYCYCLINE; ERTAPENEM; ERYTHROMYCIN; GEMIFLOXACIN; GENTAMICIN; IMIPENEM; INFLUENZA VACCINE; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PNEUMOCOCCUS VACCINE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN; UNINDEXED DRUG;

ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL STEWARDSHIP PROGRAM; ANTIMICROBIAL THERAPY; ASYMPTOMATIC BACTERIURIA; BLOOD CULTURE; BLOOD GAS ANALYSIS; CAUSE OF DEATH; CLINICAL TRIAL (TOPIC); COMMUNITY ACQUIRED PNEUMONIA; DRUG USE; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; INFECTION; INFECTION PREVENTION; INFLUENZA; MONOTHERAPY; PATIENT CARE; PATIENT COUNSELING; PERFORMANCE MEASUREMENT SYSTEM; PNEUMONIA; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; REVIEW; SMOKING CESSATION; STANDARDIZATION; SURGICAL INFECTION; URINARY TRACT INFECTION; VACCINATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIURIA; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HOSPITALS; HUMANS; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC; PUBLIC HEALTH; QUALITY OF HEALTH CARE; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 79961005770     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir364     Document Type: Review

References (48)

1. Metersky ML, Abend SL, Meehan TP. What have we learned about how to measure quality of care for patients with community-acquired pneumonia? Respir Care Clin N Am 2005; 11:87-98. (Pubitemid 40347807)
2. Bratzler DW, Nsa W, Houck PM. Performance measures for pneumonia: are they valuable and are process measures adequate? Curr Opin Infect Dis 2007; 20:182-9. (Pubitemid 46340802)
3. Centers for Medicare and Medicaid Services and the Joint Commission. Specifications manual for national hospital inpatient quality measures. Available at: http://www.jointcommission.org/specifications-manual-for-national- hospital-inpatient-quality-measures/. Accessed 1 May 2011.
4. Buie VC, Owings MF, DeFrances CJ, Golosinskiy A. National hospital discharge survey: 2006 summary. National Center for Health Statistics. Vital Health Stat 2010; 13:1-79.
5. File TM Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med 2010; 122:130-41.
6. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2):S27-72. (Pubitemid 46290553)
7. File TM Jr, Gross PA. Performance measurement in communityacquired pneumonia: consequences intended and unintended. Clin Infect Dis 2007; 44:942-4. (Pubitemid 46452058)
8. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278:2080-4. (Pubitemid 28016230)
9. Houck PM, BratzlerDW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637-44. (Pubitemid 38392978)
10. Pines JM. Profiles in patient safety: antibiotic timing in pneumonia and pay-for-performance. Acad Emerg Med 2006; 13:787-90. (Pubitemid 43928653)
11. Friedberg MW, Mehrotra A, Linder JA. Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients? Am J Manag Care 2009; 15:137-44.
12. Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of communityacquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007; 131: 1865-9. (Pubitemid 46981647)
13. Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med 2008; 168:351-6. (Pubitemid 351347125)
14. Shorr AF, Owens RC Jr. Guidelines and quality for communityacquired pneumonia: measures from the Joint Commission and the Centers for Medicare and Medicaid Services. Am J Health Syst Pharm 2009; 66(12 Suppl 4):S2-7.
15. Metersky ML, Sweeney TA, Getzow MB, Siddiqui F, Nsa W, Bratzler DW. Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours? Chest 2006; 130:16-21. (Pubitemid 44116837)
16. Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(Suppl 1):S51-61.
17. Institute for Healthcare Improvement. 5 million lives campaign. Getting started kit: prevent surgical site infections how-to guide. Available at: http://www.ihi.org/IHI/Programs/Campaign/Campaign.htm?TabId52. Accessed 15 November 2010.
18. Anderson DJ, Chen LF, Sexton DJ, Kaye KS. Complex surgical site infections and the devilish details of risk adjustment: important implications for public reporting. Infect Control Hosp Epidemiol 2008; 29:941-6.
19. Hidron AI, Edwards JR, Patel J, et al. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008; 29:996-1011.
20. Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 2010; 303:2479-85.
21. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006; 43:322-30. (Pubitemid 44088320)
22. Engelman R, Shahian D, Shemin R, et al. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg 2007; 83:1569-76.
23. Avni T, Levcovich A, Ad-EI DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ 2010; 340:c241.
24. Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006; 355:2640-51. (Pubitemid 44969123)
25. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189:395-404. (Pubitemid 40488232)
26. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362:9-17.
27. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillinresistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med 2011; 171:68-73.
28. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40:643-54. (Pubitemid 40381336)
29. Lin K, Fajardo K. Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2008; 149:W20-4.
30. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2001; (2):CD000490.
31. Mittendorf R, Williams MA, Kass EH. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis 1992; 14:927-32.
32. Cafferkey MT, Falkiner FR, Gillespie WA, Murphy DM. Antibiotics for the prevention of septicaemia in urology. J Antimicrob Chemother 1982; 9:471-7. (Pubitemid 12031495)
33. Harding GK, Zhanel GG, Nicolle LE, Cheang M. Manitoba Diabetes Urinary Tract Infection Study Group. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347:1576-83. (Pubitemid 35315838)
34. Warren JW, Anthony WC, Hoopes JM, Muncie HL Jr. Cephalexin for 490 susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA 1982; 248:454-8. (Pubitemid 12081752)
35. Boscia JA, Kobasa WD, Knight RA, Abrutyn E, Levison ME, Kaye D. Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women. JAMA 1987; 257:1067-71. (Pubitemid 17031496)
36. Nordenstam GR, Brandberg CA, Odén AS, Svanborg én CM, SvanborgA. Bacteriuria and mortality in an elderly population. N Engl J Med 1986; 314:1152-6. (Pubitemid 16138662)
37. Nicolle LE, Mayhew WJ, Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in in-500 stitutionalized elderly women. Am J Med 1987; 83:27-33. (Pubitemid 18099023)
38. Nicolle LE, Bjornson J, Harding GK, MacDonell JA. Bacteriuria in elderly institutionalized men. N Engl J Med 1983; 309:1420-5. (Pubitemid 14245138)
39. Dalen DM, Zvonar RK, Jessamine PG. An evaluation of the management of asymptomatic catheter-associated bacteriuria and candiduria at The Ottawa Hospital. Can J Infect Dis Med Microbiol 2005; 16: 166-70. (Pubitemid 41113431)
40. Gandhi T, Flanders SA, Markovitz E, Saint S, Kaul DR. Importance of urinary tract infection to antibiotic use among hospitalized patients. Infect Control Hosp Epidemiol 2009; 30:193-5.
41. Cope M, Cevallos ME, Cadle RM, Darouiche RO, Musher DM, Trautner BW. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis 2009; 48: 1182-8.
42. Chant C, Dos Santos CC, Saccucci P, Smith OM, Marshall JC, Friedrich JO. Discordance between perception and treatment practices associated with intensive care unit-acquired bacteriuria and funguria: a Canadian physician survey. Crit Care Med 2008; 36: 1158-67. (Pubitemid 351482665)
43. Loeb M, Brazil K, Lohfeld L, et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ 2005; 331:669.
44. Zabarsky TF, Sethi AK, Donskey CJ. Sustained reduction in inappropriate treatment of asymptomatic bacteriuria in a long-term care facility through an educational intervention. Am J Infect Control 2008; 36:476-80.
45. Bonnal C, Baune B, Mion M, et al. Bacteriuria in a geriatric hospital: impact of an antibiotic improvement program. J Am Med Dir Assoc 2008; 9:605-9.
46. Pavese P, Saurel N, Labarere J, et al. Does an educational session with an infectious diseases physician reduce the use of inappropriate antibiotic therapy for inpatients with positive urine culture results? A controlled before-and-after study. Infect Control Hosp Epidemiol 2009; 30:596-9.
47. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29:745-58. (Pubitemid 30256361)
48. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:625-63.